| Not Yet Recruiting | Effect of Adding TENS to Mediterranean Diet on Appetite and Liver Enzymes in Nonalcoholic Fatty Liver Patients NCT07200934 | Cairo University | N/A |
| Withdrawn | A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH NCT06692283 | Sagimet Biosciences Inc. | Phase 3 |
| Withdrawn | A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis NCT06594523 | Sagimet Biosciences Inc. | Phase 3 |
| Recruiting | Effect of a GnRH Analog on Hepatic Steatosis NCT06523530 | Aristotle University Of Thessaloniki | Phase 4 |
| Recruiting | Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity NCT06335771 | Bettina Mittendorfer | N/A |
| Recruiting | Digital Therapy for Fatty Liver Disease NCT07007741 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | N/A |
| Active Not Recruiting | Accurate Point of Care Liver Disease Diagnostics NCT05986916 | University of California, San Diego | — |
| Unknown | Cardio-Metabolic Risk Evaluation in Overweight and Obese Children NCT05908877 | Neoped - Centru de Pediatrie | — |
| Completed | Conditionally Increased Output (CIO) Enhanced Ultrasound System NCT05792423 | Massachusetts General Hospital | N/A |
| Completed | Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis NCT05680233 | Oasis Pharmaceuticals, LLC | Phase 1 |
| Active Not Recruiting | Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease NCT05493761 | Aristotle University Of Thessaloniki | Phase 4 |
| Completed | The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease NCT05364684 | Massachusetts General Hospital | Phase 2 |
| Unknown | Study on GS300 on NAFLD NCT04887766 | Gelesis, Inc. | N/A |
| Recruiting | Metabolic Pathology of Pediatric NAFLD NCT05430178 | University of Oklahoma | N/A |
| Active Not Recruiting | Weight, Energy, Lipids, and the Liver (WELL) Study NCT05199948 | Ohio State University | N/A |
| Completed | Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study NCT05309642 | Ewha Womans University Mokdong Hospital | N/A |
| Completed | Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2 NCT05081427 | Mayo Clinic | — |
| Unknown | Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease NCT05084404 | Yokohama City University | Phase 2 |
| Completed | Noninvasive Biomarkers of Metabolic Liver Disease 1.1 NCT04828551 | Massachusetts General Hospital | N/A |
| Active Not Recruiting | Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes NCT04595474 | Joslin Diabetes Center | — |
| Completed | Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease NCT04235205 | Yokohama City University | Phase 2 |
| Completed | Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease NCT04031729 | Massachusetts General Hospital | Phase 1 / Phase 2 |
| Completed | A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD NCT03950882 | Poxel SA | Phase 1 |
| Completed | Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1 NCT04389593 | University of California, San Diego | — |
| Completed | Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease NCT03696797 | Wake Forest University Health Sciences | N/A |
| Completed | A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD NCT03763877 | Poxel SA | Phase 2 |
| Recruiting | Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance NCT05165706 | Stanford University | N/A |
| Not Yet Recruiting | Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in Chinese NCT03282305 | Great China Fatty Liver Consortium Limited | — |
| Completed | Feasibility of VIIT in Adults With NASH NCT03861819 | Duke University | N/A |
| Completed | The Liver Health Study for Patients with NAFLD NCT03151798 | University of Missouri-Columbia | N/A |
| Completed | Curcumin Supplement in Nonalcoholic Fatty Liver Patients NCT02908152 | National Nutrition and Food Technology Institute | Phase 2 / Phase 3 |
| Completed | Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease NCT03986684 | Hippocration General Hospital | — |
| Unknown | Crassostrea Gigas for Liver Health NCT02992470 | Korean Medicine Hospital of Pusan National University | N/A |
| Unknown | Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD NCT03725631 | Korea University Guro Hospital | N/A |
| Recruiting | A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions NCT02815891 | Target PharmaSolutions, Inc. | — |
| Terminated | Fatty Liver Study in Patients With Type II Diabetes NCT02365233 | The University of Texas Medical Branch, Galveston | Phase 4 |
| Completed | Vitamin D Replacement in Nonalcoholic Fatty Liver Disease NCT03084328 | The Cleveland Clinic | — |